Join Bold Brain
Join Bold Brain
logotype
Join BoldBrain
logotype

Trending News in Healthcare AI

Elucid anticipates broader adoption of coronary plaque analysis

Elucid’s Plaque-IQ image analysis software is now reportable under Category I Current Procedural Terminology (CPT) code 75577.

Effective January 1, 2026, the development underscores the clinical value of quantitative coronary plaque analysis and establishes favorable conditions for broader adoption of the technology, according to Elucid. The firm said payers Aetna, Humana, Cigna, and UnitedHealthcare have all aligned with coverage.

https://www.auntminnie.com/clinical-news/ct/news/15814328/elucid-anticipates-broader-adoption-of-coronary-plaque-analysis?utm_campaign=2026-01-12&utm_source=AuntMinnie-Letter+From+The+Editor&since=1768284000000&braze_int_id=645298bc8cca4f00018b7b7c&braze_ext_id=643033d719ef38833c626b74&utm_medium=email

Picture of Robin Prasad, Managing Partner, MD, MS, MBA

Robin Prasad, Managing Partner, MD, MS, MBA

Dr. Robin Prasad is a Managing Partner at Bold Brain and a board-certified radiologist with fellowship training in MRI and Neuroradiology. He has over 20 years of experience as a radiologist and has worked in a variety of clinical environments.

You can view additional blog posts here:  Bold Brain Blog

Our Portfolio of Companies